KIMBERLY FLOWERS: Open Payments
NPI 1811387947 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,580 in 74 payments from 19 companies in 2025. Trend: 2023 $54 · 2024 $801 · 2025 $1,580
Food & beverage: $1,580
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $588 |
| ANI Pharmaceuticals, Inc. | 5 | $156 |
| UCB, Inc. | 7 | $126 |
| Novo Nordisk Inc | 1 | $125 |
| Dexcom, Inc. | 1 | $84 |
| Janssen Biotech, Inc. | 4 | $82 |
| Alexion Pharmaceuticals, Inc. | 3 | $62 |
| Lilly USA, LLC | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Mallinckrodt Hospital Products Inc. | 2 | $35 |
Products named: RINVOQ, PURIFIED CORTROPHIN GEL, Bimzelx, Wegovy, VRAYLAR, Dexcom G6 Transmitter, TREMFYA, STRENSIQ.
Industry payments across AL — which companies pay providers there.
